Roger Newton

Tim Mayleben Named President And CEO Of Esperion Therapeutics

Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.

WWJ Newsradio 950–2013/01/06